Warning: Use of undefined constant DOCUMENT_ROOT - assumed 'DOCUMENT_ROOT' (this will throw an Error in a future version of PHP) in /data/www/iasliver.org/iasl2021/inc/head.php on line 2
IASL 2021
Warning: Use of undefined constant DOCUMENT_ROOT - assumed 'DOCUMENT_ROOT' (this will throw an Error in a future version of PHP) in /data/www/iasliver.org/iasl2021/inc/head.php on line 38

PROGRAM

GMT+09:00 (Korea, Japan)

ROOM 1

JOINT 2

IASL & South America

Jul. 17 07:10-07:30

Long-Term Albumin Administration in Patients with Cirrhosis: How Good Is It?

Melissa Dirchwolff (Hospital Privado de Rosario, Argentina)

Jul. 17 07:30-07:50

Advances in Hepatic Encephalopathy

Manuela Merli (Sapienza University of Rome, Italy)

Jul. 17 07:50-08:10

Diagnosis and Impact of Sarcopenia in Patients with Cirrhosis

Juan Pablo Arab (Pontificia Universidad Catolica de Chile, Chile)

Jul. 17 08:10-08:30

Management of Bacterial Infections

Sebastian Marciano (Hospital Italiano de Buenos Aires, Argentina)

Jul. 17 08:30-08:50

Discussion

Session 9

Portal Hypertension in the 21st Century

Jul. 17 09:00-09:20

Where Are We Moving into Prevention and Treatment of Portal Hypertension?

Andres Cardenas (University of Barcelona, Spain)

Jul. 17 09:20-09:40

Recent Diagnostic Approah for Portal Hyertension

Moon Young Kim (Yonsei University Wonju, Korea)

Jul. 17 09:40-10:00

Variceal Bleeding - Update in Prevention and Treatment

Alexander Nersesov (Kazakh National Medical University, Kazakhstan)

Jul. 17 10:00-10:20

Is There a Global Perspective for Early and Elective TIPS-Implantation?

Virginia Hernandez-Gea (University of Barcelona, Spain)

Jul. 17 10:20-10:40

Discussion

Session 11

Complications of Cirrhosis

Jul. 17 10:50-11:10

Cirrhotic Cardiomyopathy: Comparing Old and New Definition Criteria

Marcel Razpotnik (Klinikum Klagenfurt am Wörthersee, Austria)

Jul. 17 11:10-11:30

Adverse Cardiovascular Events after Liver Transplantation

Manhal Izzy (Vanderbilt University Medical Center, USA)

Jul. 17 11:30-11:50

Update in Hepatopulmonary Syndrome and Portopulmonary Hypertension

Samir Gupta (University of Toronto, Canada)

Jul. 17 11:50-12:10

Advances in Hepatorenal Syndrome and Acute Kidney Injury

Florence Wong (University of Toronto, Canada)

Jul. 17 12:10-12:30

Discussion

Jul. 17 12:30-13:30

Lunch Break

Session 12

Management in Fatty Liver Disease

Jul. 17 13:30-13:50

Exercise to Improve Fatty Liver and Portal Hypertension

Takumi Kawaguchi (Kurume University, Japan)

Jul. 17 13:50-14:10

Nutritional Interventions for Fatty Liver Disease on the West

Shira Zelber-Sagi (University of Haifa, Israel)

Jul. 17 14:10-14:30

Awareness for Fatty Liver Disease - Are We Making Any Global Progress?

Faisal Sanai (King Saud University, Saudi Arabia)

Jul. 17 14:30-14:50

Pediatric Fatty Liver Disease and Risk of Adult Complications

Henning Grønbæk (Aarhus University, Denmark)

Jul. 17 14:50-15:10

Discussion

Presidential Lecture

Jul. 17 15:20-15:50

To Be Confirmed

Kwang-Hyub Han (NECA, Korea)

Session 13

Alcoholic Liver Disease in the 21 Century

Jul. 17 16:00-16:20

Alcoholic Hepatitis - How Can We Modify the Course?

Mark Thursz (Imperial College London, UK)

Jul. 17 16:20-16:40

Gut Microbiota and Alcoholic Liver Disease

Dong Joon Kim (Hallym University, Korea)

Jul. 17 16:40-17:00

Genetic Susceptibility to Alcoholic Liver Damage - Global Perspective

Felix Stickel (Hirslanden Private Hospital Group, Switzerland)

Jul. 17 17:00-17:20

Alcoholic Liver Damage - Best Practice for Public Health Improvement

Jürgen Rehm (University of Toronto, Canada)

Jul. 17 17:20-17:40

Discussion

Jul. 17 17:40-18:00

Wrap-Up & Closing

Markus Peck, President-Elect

ROOM 2

Session 10

Non-Invasive Assessment of Liver Fibrosis: A Case Based Approach

Jul. 17 09:00-09:20

Non-Alcoholic Fatty Liver Disease

Laurent Castera (University of Paris-VII, France)

Jul. 17 09:20-09:40

Chronic Hepatitis B

Seung Up Kim (Yonsei University, Korea)

Jul. 17 09:40-10:00

Cirrhosis

Massimo Pinzani (University College London, UK)

Jul. 17 10:00-10:20

Assessment of HCC Risk

Henry LY Chan (The Chinese University of Hong Kong, China)

Jul. 17 10:20-10:40

Discussion

JOINT 3

IASL & KLCA: HCC - Recent Advances in Prevention and Treatment

Jul. 17 13:00-13:15

The Changing Global Epidemiology and Prevention

Jidong Jia (Capital Medical University, China)

Jul. 17 13:15-13:30

AI-Prediction Model of HCC in Patients with Chronic Hepatitis B

Jeong-Hoon Lee (Seoul National University, Korea)

Jul. 17 13:30-13:45

Tenofovir vs. Entecavir for the Prevention of HCC

Sung Won Lee (The Catholic University of Korea, Korea)

Jul. 17 13:45-14:00

HCC Surveillance and Diagnosis in 2021

Mindie H. Nguyen (Stanford University, USA)

Jul. 17 14:00-14:15

Imaging Diagnosis of Macrotrabecular-Massive HCC

Hyungjin Rhee (Yonsei University, Korea)

Jul. 17 14:15-14:30

Application of AI in HCC Treatment

Gwang Hyeon Choi (Seoul National University, Korea)

Jul. 17 14:30-14:45

Pursuing Efficacious Combination Treatment for HCC

Ann-Lii Cheng (National Taiwan University, Taiwan)

Jul. 17 14:45-15:00

Sequential Treatment for Advanced HCC based on Real-World-Data

Masatoshi Kudo (Kindai University, Japan)

Jul. 17 15:00-15:20

Discussion